In most of the published studies on IGM, however, prolactin levels were not evaluated, and only a minority of published cases have been linked to hyperprolactinemia, e.g., due to antipsychotic medication or intracranial tumors such as pituitary adenomas [21]. This evidence concerns the gene PRL and hyperprolactinemia.